Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optic neuropathy and amiodarone therapy.

L A Feiner, B R Younge, F J Kazmier

    Mayo Clinic Proceedings
    |August 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Are higher antidepressant plasma concentrations associated with fall risk in older antidepressant users?

    European geriatric medicine·2023
    Same author

    Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.

    PloS one·2022
    Same author

    Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults.

    PloS one·2022
    Same author

    Appendectomy and the subsequent risk of cancer: A prospective population-based cohort study with long follow-up.

    Cancer epidemiology·2022
    Same author

    A Propensity Score Matched Approach to Assess the Associations of Commonly Prescribed Medications with Fall Risk in a Large Harmonized Cohort of Older Ambulatory Persons.

    Drugs & aging·2021
    Same author

    Prevalence of and risk factors for extended-spectrum beta-lactamase genes carriership in a population-based cohort of middle-aged and elderly.

    International journal of antimicrobial agents·2021

    Amiodarone can cause optic neuropathy, a milder condition than typically seen. Regular eye exams are recommended for patients on this drug to monitor for potential vision loss.

    Area of Science:

    • Ophthalmology
    • Cardiology
    • Pharmacology

    Background:

    • Amiodarone is a potent antiarrhythmic drug used for life-threatening cardiac arrhythmias.
    • Optic neuropathy is a potential adverse effect associated with amiodarone treatment.

    Observation:

    • This report details 13 amiodarone-treated patients diagnosed with optic neuropathy.
    • The observed drug-related optic neuropathy presented with milder clinical severity compared to anterior ischemic optic neuropathy.

    Findings:

    • The incidence of amiodarone-induced optic neuropathy was significantly higher than in the general population.
    • The exact cause remains uncertain, potentially involving amiodarone therapy, patient health, or a combination.

    Implications:

    Related Experiment Videos

    • Complete ophthalmologic examinations are recommended for all amiodarone recipients.
    • Early detection of optic neuropathy may allow for drug discontinuation to prevent vision loss.
    • The benefits of amiodarone for cardiac arrhythmias appear to outweigh the risk of optic neuropathy.